Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CamBMT1: Afatinib Penetration in Brain Metastases
NCT02768337Phase 2Terminated
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Mar 2015
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of afatinib in brain metastases, sponsored by Cambridge University Hospitals NHS Foundation Trust. Started Mar 2015; status: terminated.
02
Drugs
afatinib
03
Conditions
brain metastases
Beyond the preview
Go deeper on NCT02768337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02768337.